Business Wire

Wipro, CloudGenix Partner to Deliver Managed SD-WAN Services

Jaa

Wipro Limited(NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company and CloudGenix Inc., a leading provider of Software-Defined Wide Area Networking (SD-WAN) products, today announced a partnership to offer open and managed SD-WAN services. Termed as WANFreedom, the service allows enterprise customers to rapidly deploy cloud, SaaS (Software as a Service) and data center applications over any combination of MPLS (Multiprotocol Label Switching), Internet broadband and LTE (Long Term Evolution) networks, thereby enabling a rich user experience and IT infrastructure cost optimization.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170926006047/en/

Traditional WAN products based on proprietary hardware and complex routing protocols result in substantial dependencies and inhibit cloud adoption. With WANFreedom, customers will be freed from dependencies on WAN transport, proprietary hardware routers, networking complexity, therefore freeing up IT teams to focus on rapidly delivering business value.

Over the next five years, SD-WAN sales are forecast to grow at a 69.6% compound annual growth rate, reaching $8.05 billion in 2021, according to the IDC Worldwide SD-WAN Forecast: 2017–2021 (doc #US42904317, July 2017) report. This growth is fueled by rapid adoption of cloud, SaaS and data center applications, the commoditization of connectivity boosted by low-cost and high-capacity broadband availability, and the digitization of remote offices.

Kiran Desai, Senior Vice President & Global Head, Global Infrastructure Services, Wipro Limited said, “By partnering with CloudGenix, Wipro now offers its customers an end-to-end managed WAN, delivering a host of benefits including WAN transport independence, the ability to seamlessly integrate multiple telecom and network carriers and WAN types, improved WAN availability, uncompromised access to cloud, SaaS and rich media applications, elimination of proprietary hardware routers, and significant cost savings. These capabilities provide enterprises the freedom to adopt cloud, UCaaS (Unified Communications as a Service), SaaS and other modern applications without compromising security, performance, or visibility.”

Kumar Ramachandran, CEO, CloudGenix said, “Wipro is a recognized global leader in deploying, managing, and operationalizing network infrastructure. Wipro’s WAN assessment and prescriptive service delivery model ensures customers gain instant time to value without needing to ‘rip and-replace’ their legacy WAN infrastructure.”

Wipro’s SD-WAN capabilities meet enterprise customers’ digital business needs while ensuring robust performance, security and compliance in line with their business application policies. Supported by its Software Defined Everything (SDx) Center Of Excellence and ServiceNXT, a next-generation managed services framework, Wipro’s enterprise assessment and consultancy services ensure efficient delivery of SD-WAN solution for clients.

CloudGenix’s SD-WAN is powered by CloudGenix AppFabric that enables a self-healing network built on machine learning, which ensures faster time to market and better response to business needs.

About Wipro Limited

Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO) is a leading global information technology, consulting and business process services company. We harness the power of cognitive computing, hyper-automation, robotics, cloud, analytics and emerging technologies to help our clients adapt to the digital world and make them successful. A company recognized globally for its comprehensive portfolio of services, strong commitment to sustainability and good corporate citizenship, we have over 160,000 dedicated employees serving clients across six continents. Together, we discover ideas and connect the dots to build a better and a bold new future.

About CloudGenix

CloudGenix (www.cloudgenix.com) is the software-defined wide-area network (SD-WAN) leader, revolutionizing networking by transforming legacy WANs into a radically simplified, secure, application-defined fabric and unified hybrid WAN. Enabling application-specific, service-level agreements (SLAs), CloudGenix controls network application performance based upon application-performance SLAs and business priority. CloudGenix ION (Instant-On Network) simplifies how WANs are designed and managed, enabling customers to build “networks without networking,” and achieve more than twice the performance at less than half the cost while extending data center-class security to the network edge. Founded in 2013 by a team that has delivered industry-leading products in networking, SDN, cloud, security and web-scale applications, CloudGenix serves world-class financial services, legal, retail and technology organizations.

Forward-looking and Cautionary Statements

Certain statements in this release concerning our future growth prospects are forward-looking statements, which involve a number of risks, and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in our earnings, revenue and profits, our ability to generate and manage growth, intense competition in IT services, our ability to maintain our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, the success of the companies in which we make strategic investments, withdrawal of fiscal governmental incentives, political instability, war, legal restrictions on raising capital or acquiring companies outside India, unauthorized use of our intellectual property, and general economic conditions affecting our business and industry. Additional risks that could affect our future operating results are more fully described in our filings with the United States Securities and Exchange Commission. These filings are available at www.sec.gov. We may, from time to time, make additional written and oral forward-looking statements, including statements contained in the company’s filings with the Securities and Exchange Commission and our reports to shareholders. We do not undertake to update any forward-looking statement that may be made from time to time by us or on our behalf.

Contact information

Wipro Limited
Prathibha Das
prathibha.das@wipro.com
or
CloudGenix
Joel Christner
pr@cloudgenix.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Pharnext to Announce Top-Line Results from the Pivotal Phase 3 Trial of PXT3003 for the Treatment of Charcot-Marie-Tooth Type 1A Disease by October 201821.6.2018 21:23Tiedote

Regulatory News: Pharnext SA (Paris:ALPHA) (FR0011191287 - ALPHA), a biopharmaceutical company pioneering a new approach to the development of innovative drug combinations based on big data genomics and artificial intelligence, today announced an update from its ongoing Phase 3 clinical program (PLEO-CMT and PLEO-CMT-FU studies) evaluating PXT3003 for the treatment of Charcot-Marie-Tooth type 1A disease (CMT1A) in adults. Top-line results from the pivotal PLEO-CMT study are now expected by October 2018. Prof. Daniel Cohen, M.D., Ph.D., Pharnext’s Co-Founder and Chief Executive Officer said: “We are thrilled to bring this Phase 3 clinical trial to completion and we now expect to disclose top-line results by October of this year. Our PLEODRUG™ PXT3003 has already shown initial signals of efficacy in our Phase 2 trial in CMT1A. We are hopeful we can bring this much-needed therapy to patients suffering from this debilitating condition, as they currently have limited therapeutic options, mo

Philip Morris International Makes Call to Creative, Media and Communications Communities21.6.2018 21:13Tiedote

Philip Morris International Inc. (“PMI”) (NYSE: PM), today announced a bold call to action for the creative, media and communications communities to embrace its ongoing commitment to creating a smoke-free world. As part of this initiative, PMI will offer smoke-free alternatives wherever we can, including heated tobacco products and e-cigarettes, to current smokers in the industry who would otherwise continue to smoke. During a keynote at the PMI Science Lounge at The Cannes Festival of Creativity, SVP of Communications Marian Salzman said, “We are asking the creative community to join us in raising awareness of the potential of science, technology and innovation for those who smoke and the people around them.” The move is part of PMI’s vision to lead the charge towards greater innovation and technology in the tobacco industry, all of which is backed by science. Agencies interested in joining the movement can contact Marian Salzman at marian.salzman@pmi.com. “People who smoke deserve in

IBC2018 Announces Cyber Security Forum to Help Media Tackle Cyber Threats21.6.2018 19:30Tiedote

IBC2018, the world’s most influential media, entertainment and technology show, today announces a Cyber Security Forum to expand its position as the preeminent cyber security destination for broadcasters and media. The event will form part of the prestigious annual IBC show at the RAI in Amsterdam from Thursday 13 to Tuesday 18 September 2018, which last year attracted more than 57,000 attendees from 170 countries. The Cyber Security Forum is one-day, invitation-only event that will convene Chief Technology Officers, Chief Information Officers, Chief Information Security Officers and Chief Digital Officers within media and broadcasting for a conversation on the challenges and opportunities presented by cyber security for broadcasters. Attendees will discuss how to anticipate the next cyber threat, how to manage a breach and how to prepare for the future of cyber security. The Cyber Security Forum sits alongside the Telco & Media Innovation Forum and Leaders’ Forum as part of IBC’s Exec

Mensia Technologies Raises 1,3 Million Euro to Introduce Koala Neurofeedback as a Revolutionary Medical Device in Europe21.6.2018 19:23Tiedote

Mensia Technologies, french MedTech start up, leads the new booming category of Digital therapeutics with its revolutionary « at home « neurofeedback, to train the brain and cure neuropsy disorders without drugs. Co-founder INRIA-IT2, existing shareholders and now HARA, which are business angels experts in medical device category, joined this fund raise. BPI de Rennes is also part of this tour. Mensia Technologies, borned out of INRIA in 2012. The IT expert labs in Rennes are computing real time signaling softwares. The neurofeedback technique is non invasive, at home and without drugs. MENSIA KOALA treats ADHD, Attention Deficit Disorders with or without Hyperactivity, children and adolescents. This unique medical device is a therapeutic video game on an interactive tablet connected to the brain activity. Children learn to control their attention by exercising 3 times a week during 4 months of treatment. Visual feedback given during the game, allows the children to learn, control and

Phlexglobal to Improve eTMF Document Transfers with Adoption of New Exchange Mechanism Standard21.6.2018 19:16Tiedote

Phlexglobal, a specialist provider of technology-enabled Trial Master File (TMF & eTMF) management solutions, is adopting Version 1 of the eTMF Exchange Mechanism Standard (eTMF-EMS) of the TMF Reference Model (TMF-RM) into PhlexEview, the company’s eTMF technology. This marks a major advancement in efficient document interchange and will firmly solidify Phlexglobal’s position as a driving force in eTMF management for clinical trials. Prior to the creation of the TMF Reference Model, there was no universal methodology for the organization of trial data in an eTMF. In 2009 Phlexglobal joined other industry TMF experts to create the TMF Reference Model which has primarily focused on organizing the artifacts of a clinical trial. While the TMF-RM has aided in the organization of artifact, the transfer of TMF to trial sponsors or contract research organizations has often required a significant amount of mapping and manipulation. Phlexglobal has extensive experience migrating millions of TMF

IDEMIA: Enter the World of Augmented Identity at our Pop-up Innovation Center in London (25th-27th June 2018)21.6.2018 17:36Tiedote

IDEMIA, the global leader in Augmented Identity, is announcing the opening of its Pop-up Innovation Center, at the heart of London, in Westminster (“Queen Elizabeth II Center”). It will take place from 25th to 27th of June, 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180621005800/en/ IDEMIA’s ambition is to enable a secure and trusted environment for citizens and consumers alike to perform their daily critical activities (such as pay, connect, travel, vote or access public or private spaces), in the real as well as digital worlds. Opening its unique Pop-up Innovation Center, IDEMIA invites you to experience its innovative solutions through dedicated demonstration areas. IDEMIA will showcase a wide range of innovations, such as: Identity on the move: secure biometric systems to manage the flow of people The mobile generation: a new solution to put your ID in your smartphone, in a safe way - under your control and wit

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme